KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) EPS (Basic): 2010-2025

Historic EPS (Basic) for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $0.96.

  • Emergent BioSolutions' EPS (Basic) fell 55.56% to $0.96 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.42, marking a year-over-year increase of 136.13%. This contributed to the annual value of -$3.60 for FY2024, which is 75.76% up from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' EPS (Basic) is $0.96, which was up 536.36% from -$0.22 recorded in Q2 2025.
  • Emergent BioSolutions' 5-year EPS (Basic) high stood at $3.62 for Q4 2021, and its period low was -$5.38 during Q2 2024.
  • Its 3-year average for EPS (Basic) is -$1.50, with a median of -$0.57 in 2024.
  • As far as peak fluctuations go, Emergent BioSolutions' EPS (Basic) crashed by 10,500.00% in 2022, and later surged by 635.29% in 2025.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' EPS (Basic) stood at $3.62 in 2021, then plummeted by 137.02% to -$1.34 in 2022, then surged by 34.33% to -$0.88 in 2023, then skyrocketed by 35.23% to -$0.57 in 2024, then crashed by 55.56% to $0.96 in 2025.
  • Its EPS (Basic) stands at $0.96 for Q3 2025, versus -$0.22 for Q2 2025 and $1.25 for Q1 2025.